Oxidative stress‐induced dysfunction of nerve cells has been implicated as a crucial cause of cell death in neurodegenerative diseases. In Asian countries, herbs, such as Angelica sinensis (Oliv.) Diels (DG) and Rehmannia glutinosa (Gaertn.) DC. (SDH), have long be considered to have antiaging abilities. The herbs act as neuro protectants that rescue nerve cells from oxidative stress damage and apoptosis. Thus, developing herbal formulas can potentially lead to new treatments for neurodegenerative diseases. In this study, we compared the effective active components and antioxidant properties of extractive of DG and SDH (DG‐SDH) when formulated at different ratios. DG‐SDH formulated at a ratio of 3:2 (DG‐SDH [3:2]) produced the highest content of polysaccharides, polyphenols, and flavonoids. It also showed the best ability in removing DPPH and hydroxyl free radicals compared to single herb or other compounding ratio. The antioxidant activity of DG‐SDH (3:2) showed best synergistic effects in scavenging activity assays of DPPH free radicals and hydroxyl free radicals. DG‐SDH (3:2) could increase the cell viability of SHSY‐5Y cells, PC‐12 cells, and BV‐2 cells. In particular, DG‐SDH (3:2) protected SHSY‐5Y cells from H2O2‐induced cell injury by inhibiting excessive expression of reactive oxygen species (ROS), reducing the rate of apoptosis and restoring mitochondrial membrane potential. Actin‐Tracker Green and DAPI staining and fluorescence microscope observation confirmed that DG‐SDH (3:2) helped in preserving cell morphology under oxidative stress. These findings support that DG‐SDH (3:2) promote the neuroprotection against hydrogen peroxide and can serve as a novel therapy for neurodegenerative diseases.
Practical applications
This is the first study to investigate DG and SDH interaction between effective ingredients. These findings support that DG‐SDH (3:2) has the best synergistic effects in antioxidant activity and promote the neuroprotection against hydrogen peroxide. Hence, DG‐SDH (3:2) will be an excellent candidate to be developed as a functional food ingredients or nutraceuticals for neurodegenerative diseases.
Objective:Determining nano-lanthanum hydroxide in the treatment of hyperphosphatemia compared to other phosphate binders with higher potency and therapeutic advantages. Methods: We used three kinds of phosphorus binders(nano-lanthanum hydroxide, lanthanum carbonate and normal size lanthanum hydroxide) agent on adenine-induced model of renal failure hyperphosphatemia in rats , and then we detected of physiological and biochemical indicators and observed immunohistochemistry experiments to determine the efficacy of each drug. Results: The therapeutic effect of nanometer lanthanum hydroxide middle dose group in rat hyperphosphatemia model was better than other groups. In drug's safety, no side effects were observed in rats in long-term administration. Conclusion: The titer of nanometer lanthanum hydroxide in several phosphorus binders is obvious, which is better than lanthanum carbonate of FDA-listed fusilino and normal size lanthanum hydroxide. It has better therapeutic advantages, safety is reliable,side effects are very little or not.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.